L-Arginine currents in rat cardiac ventricular myocytes

Journal of Physiology

Volumn 580, Issue 3, 2007, Pages 925-936

  Peluffo, R Daniel ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ARGININE; CALCIUM ION; MAGNESIUM ION; N ETHYLMALEIMIDE; NITRIC OXIDE; ORNITHINE; POTASSIUM ION; SODIUM ION; CAT 2A PROTEIN; LYSINE; UNCLASSIFIED DRUG;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CATABOLISM; CONTROLLED STUDY; HEART MUSCLE CELL; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART MUSCLE FIBER MEMBRANE STEADY POTENTIAL; HEART PROTECTION; HEART VENTRICLE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSPORT KINETICS; VOLTAGE CLAMP; ACTIVATED INWARD CURRENT; ARGININE CURRENT; BINDING AFFINITY; CARDIAC VENTRICULAR MYOCYTE; CELL ISOLATION; CELL MEMBRANE POTENTIAL; HYPERPOLARIZATION; INCUBATION TIME; ION TRANSPORT; PROTEIN BINDING; STEADY STATE; STEREOSPECIFICITY; VOLTAGE CLAMP TECHNIQUE; WHOLE CELL PATCH CLAMP; ANIMAL; DOSE RESPONSE; DRUG EFFECT; ELECTRIC CONDUCTIVITY; EXTRACELLULAR FLUID; HEART VENTRICLE FUNCTION; HOMEOSTASIS; IN VITRO STUDY; METABOLISM; OSMOLARITY; PATCH CLAMP; PHYSIOLOGY;

ANIMALS; ARGININE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC CONDUCTIVITY; ETHYLMALEIMIDE; EXTRACELLULAR FLUID; HOMEOSTASIS; MALE; MYOCYTES, CARDIAC; NITRIC OXIDE; OSMOLAR CONCENTRATION; PATCH-CLAMP TECHNIQUES; RATS; VENTRICULAR FUNCTION;

EID: 34249845447     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.125054     Document Type: Article

References (54)

1. + channels. J Physiol 520, 165-176.
2. Aidley DJ & Stanfield PR (1996). Ion Channels. Cambridge University Press, Cambridge, UK.
3. Al-Saleh EA & Wheeler KP (1982). Transport of neutral amino acids by human erythrocytes. Biochim Biophys Acta 684, 157-171.
4. + currents in isolated adult rat ventricular myocytes. J Gen Physiol 97, 973-1011.
5. Balligand JL, Kelly RA, Marsden PA, Smith TW & Michel T (1993). Control of cardiac muscle cell function by an endogenous nitric oxide signaling system. Proc Natl Acad Sci U S A 90, 347-351.
6. Böger RH & Bode-Böger SM (2001). The clinical pharmacology of L-arginine. Annu Rev Pharmacol Toxicol 41, 79-99.
7. Bredt DS & Snyder SH (1994). Nitric oxide: A physiologic messenger molecule. Annu Rev Biochem 63, 175-195.
8. Christensen HN (1964). A transport system serving for mono- and diamino acids. Proc Natl Acad Sci U S A 51, 337-344.
9. Closs EI, Albritton LM, Kim JW & Cunningham JM (1993). Identification of a low affinity, high capacity transporter of cationic amino acids in mouse liver. J Biol Chem 268, 7538-7544.
10. Closs EI, Gräf P, Habermeier A, Cunningham JM & Förstermann U (1997). Human cationic amino acid transporters hCAT-1, hCAT-2A and hCAT-2B: Three related carriers with distinct transport properties. Biochemistry 36, 6462-6468.
11. 2+ exchange current by MgATP. J Physiol 454, 27-57.
12. Devés R, Angelo S & Chávez P (1993). N-Ethylmaleimide discriminates between two lysine transport systems in human erythrocytes. J Physiol 468, 753-766.
13. Devés R & Boyd CAR (1998). Transporters for cationic amino acids in animal cells: Discovery, structure, and function. Physiol Rev 78, 487-545.
14. Devés R & Krupka RM (1981). Evidence for a two-state mobile carrier mechanism in erythrocyte choline transport: Effects of substrate analogs on inactivation of the carrier by N-ethylmaleimide. J Membr Biol 61, 21-30.
15. Fahn S, Hurley MR, Koval GJ & Albers RW (1966). Sodium-potassium-activated adenosine triphosphatase of Electrophorus electric organ. J Biol Chem 241, 1890-1895.
16. Ferdinandy P, Danial H, Ambrus I, Rothery RA & Schulz R (2000). Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure. Circ Res 87, 241-247.
17. Grocott-Mason R, Anning P, Evans H, Lewis MJ & Shah AM (1994). Modulation of left ventricular relaxation in isolated ejecting heart by endogenous nitric oxide. Am J Physiol Heart Circ Physiol 267, H1804-H1813.
18. Harrison TR (1991). Principles of Internal Medicine. McGraw-Hill, New York.
19. Hattori Y, Shimoda S-I & Gross SS (1995). Effect of lipopolysaccharide treatment in vivo on tissue expression of argininosuccinate synthetase and argininosuccinate lyase mRNAs: relationship to nitric oxide synthase. Biochem Biophys Res Commun 215, 148-153.
20. Hecker M, Sessa WC, Harris HJ, Anggard EE & Vane JR (1990). The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: Cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci U S A 87, 8612-8616.
21. Hilgemann DW (1989). Giant excised cardiac sarcolemmal membrane patches: sodium and sodium-calcium exchange currents. Pflugers Arch 415, 247-249.
22. Hobbs AJ, Higgs A & Moncada S (1999). Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39, 191-220.
23. + type cationic amino acid transport in Xenopus oocytes and show different tissue expression patterns. Transgene 1, 91-101.
24. Kakuda DK, Finley KD, Maruyama M & MacLeod CL (1998). Stress differentially induces cationic amino acid transporter gene expression. Biochim Biophys Acta 1414, 75-84.
25. + basic amino acid transporter. Biochemistry 32, 5781-5785.
26. Kim JW, Closs EI, Albritton LM & Cunningham JM (1991). Transport of cationic amino acids by the mouse ecotropic retrovirus receptor. Nature 352, 725-728.
27. Koifman B, Wollman Y, Bogomolny N, Chernichowsky T, Finkelstein A, Peer G, Scherez J, Blum M, Laniado S, Iaina A & Keren G (1995). Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure. J Am Coll Cardiol 26, 1251-1256.
28. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y & Nagano T (1998a). Detection and imaging of nitric oxide with novel fluorescent indicators: Diaminofluoresceins. Anal Chem 70, 2446-2453.
29. Kojima H, Sakurai K, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y & Nagano T (1998 b). Development of a fluorescent indicator for nitric oxide based on the fluorescein chromophore. Chem Pharm Bull 46, 373-375.
30. + channels reveals the mechanism of augmentation by a cysteine-modifying reagent. J Neurosci 24, 5079-5090.
31. MacLeod CL & Kakuda DK (1996). Regulation of CAT: Cationic amino acid transporter gene expression. Amino Acids 11, 171-191.
32. Mendes Ribeiro AC, Brunini TMC, Ellory JC & Mann GE (2001). Abnormalities in L-arginine transport and nitric oxide biosynthesis in chronic renal and heart failure. Cardiovasc Res 49, 697-712.
33. Mitra R & Morad M (1985). A uniform enzymatic method for dissociation of myocytes from hearts and stomachs of vertebrates. Am J Physiol Heart Circ Physiol 249, H1056-H1060.
34. Nagasaki A, Gotoh T, Takeya M, Yu Y, Takiguchi M, Matsuzaki H, Takatsuki K & Mori M (1996). Coinduction of nitric oxide synthase, argininosuccinate synthetase, and argininosuccinate lyase in lipopolysaccharide-treated rats. J Biol Chem 271, 2658-2662.
35. Nawrath H, Wegener JW, Rupp J, Habermeier A & Closs EI (2000). Voltage dependence of L-arginine transport by hCAT-2A and hCAT-2B expressed in oocytes from Xenopus laevis. Am J Physiol Cell Physiol 279, C1336-C1344.
36. Nichols CG & Lederer WJ (1991). Adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Am J Physiol Heart Circ Physiol 261, H1675-H1686.
37. Noeh FM, Wenzel A, Harris N, Milakofsky L, Hofford JM, Pell S & Vogel WH (1996). The effects of arginine administration on the levels of arginine, other amino acids and related amino compounds in the plasma, heart, aorta, vena cava, bronchi and pancreas of the rat. Life Sci 58, 131-138.
38. Pan M, Choudry HA, Epler MJ, Meng Q, Karinch A, Lin C & Souba W (2004). Arginine transport in catabolic disease states. J Nutr 134, 2826S-2829S.
39. 2+ activated Cl-channels in Ehrlich ascites tumor cells are distinct from mCLCA1, 2 and 3. Pflugers Arch 442, 273-279.
40. Peluffo RD (2004). Characterization of electrogenic arginine transport in rat cardiomyocytes. Biophys J 86, 614a.
41. Peluffo RD (2005). L-arginine-activated currents in rat cardiomyocytes are consistent with cationic amino acid transport via CAT-2A. Biophys J 88, 594a.
42. Powell T, Terrar DA & Twist VW (1980). Electrical properties of individual cells isolated from adult rat ventricular myocardium. J Physiol 302, 131-153.
43. Rector TSP, Bank AJM, Mullen KAR, Tschumperlin LKR, Sih RM, Pillai KM & Kubo SHM (1996). Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 93, 2135-2141.
44. 2+ exchanger NCX1 expressed in HEK 293 cells is sensitive to covalent modification of intracellular cysteine residues by sulfhydryl reagents. J Biol Chem 276, 9572-9579.
45. Simmons WW, Closs EI, Cunningham JM, Smith TW & Kelly RA (1996). Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. J Biol Chem 271, 11694-11702.
46. Smith PA, Sakura H, Coles B, Gummerson N, Prok S & Ashcroft FM (1997). Electrogenic arginine transport mediates stimulus-secretion coupling in mouse pancreatic β-cells. J Physiol 499, 625-635.
47. Song J, Jang YY, Shin YK, Lee C & Chung S (2000). N-Ethylmaleimide modulation of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels in rat dorsal root ganglion neurons. Brain Res 855, 267-273.
48. Sperandeo MP, Borsani G, Incerti B, Zollo M, Rossi E, Zuffardi O, Castaldo P, Taglialatela M, Andria G & Sebastio G (1998). The gene encoding a cationic amino acid transporter (SLC7A4) maps to the region deleted in the velocardiofacial syndrome. Genomics 49, 230-236.
49. Stein WD (1990). Channels, Carriers, and Pumps: An Intro-duction to Membrane Transport. Academic Press, San Diego.
50. Toback FG, Mayers AM & Lowenstein LM (1973). Alterations in renal and plasma amino acid concentrations during renal compensatory growth. Am J Physiol 225, 1247-1251.
51. van Haeften TW & Konings CH (1989). Arginine pharma-cokinetics in humans assessed with an enzymatic assay adapted to a centrifugal analyzer. Clin Chem 35, 1024-1026.
52. Van Winkle LJ & Campione AL (1990). Functional changes in cation-preferring amino acid transport during development of pre-implantation mouse conceptuses. Biochim Biophys Acta 1028, 165-173.
53. Wu GY & Brosnan JT (1992). Macrophages can convert citrulline into arginine. Biochem J 281, 45-48.
54. Yamaoka K, Yakehiro M, Yuki T, Fujii H & Seyama I (2000). Effect of sulfhydryl reagents on the regulatory system of the L-type Ca channel in frog ventricular myocytes. Pflugers Arch 440, 207-215.